Literature DB >> 32857629

BAL Is Safe and Well Tolerated in Individuals with Idiopathic Pulmonary Fibrosis: An Analysis of the PROFILE Study.

Philip L Molyneaux1,2, Jonathan J Smith2, Peter Saunders1,2, Felix Chua1, Athol U Wells1,2, Elisabetta A Renzoni1,2, Andrew G Nicholson1,2, William A Fahy3, R Gisli Jenkins4, Toby M Maher1,2,5.   

Abstract

Entities:  

Mesh：

Year:  2021        PMID： 32857629      PMCID： PMC7781115          DOI： 10.1164/rccm.202004-1138LE

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN： 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  11 in total

1.  Use of a molecular classifier to identify usual interstitial pneumonia in conventional transbronchial lung biopsy samples: a prospective validation study.

Authors:  Ganesh Raghu; Kevin R Flaherty; David J Lederer; David A Lynch; Thomas V Colby; Jeffrey L Myers; Steve D Groshong; Brandon T Larsen; Jonathan H Chung; Mark P Steele; Sadia Benzaquen; Karel Calero; Amy H Case; Gerard J Criner; Steven D Nathan; Navdeep S Rai; Murali Ramaswamy; Lars Hagmeyer; J Russell Davis; Umair A Gauhar; Daniel G Pankratz; Yoonha Choi; Jing Huang; P Sean Walsh; Hannah Neville; Lori R Lofaro; Neil M Barth; Giulia C Kennedy; Kevin K Brown; Fernando J Martinez
Journal:  Lancet Respir Med       Date:  2019-04-01       Impact factor: 30.700

2.  Diagnostic accuracy of transbronchial lung cryobiopsy for interstitial lung disease diagnosis (COLDICE): a prospective, comparative study.

Authors:  Lauren K Troy; Christopher Grainge; Tamera J Corte; Jonathan P Williamson; Michael P Vallely; Wendy A Cooper; Annabelle Mahar; Jeffrey L Myers; Simon Lai; Ellie Mulyadi; Paul J Torzillo; Martin J Phillips; Helen E Jo; Susanne E Webster; Qi T Lin; Jessica E Rhodes; Matthew Salamonsen; Jeremy P Wrobel; Benjamin Harris; Garrick Don; Peter J C Wu; Benjamin J Ng; Christopher Oldmeadow; Ganesh Raghu; Edmund M T Lau
Journal:  Lancet Respir Med       Date:  2019-09-29       Impact factor: 30.700

Review 3.  Acute exacerbation of IPF following diagnostic bronchoalveolar lavage procedures.

Authors:  Koji Sakamoto; Hiroyuki Taniguchi; Yasuhiro Kondoh; Kenji Wakai; Tomoki Kimura; Kensuke Kataoka; Naozumi Hashimoto; Osamu Nishiyama; Yoshinori Hasegawa
Journal:  Respir Med       Date:  2011-12-03       Impact factor: 3.415

4.  An epithelial biomarker signature for idiopathic pulmonary fibrosis: an analysis from the multicentre PROFILE cohort study.

Authors:  Toby M Maher; Eunice Oballa; Juliet K Simpson; Joanne Porte; Anthony Habgood; William A Fahy; Aiden Flynn; Philip L Molyneaux; Rebecca Braybrooke; Hrushikesh Divyateja; Helen Parfrey; Doris Rassl; Anne-Marie Russell; Gauri Saini; Elisabetta A Renzoni; Anne-Marie Duggan; Richard Hubbard; Athol U Wells; Pauline T Lukey; Richard P Marshall; R Gisli Jenkins
Journal:  Lancet Respir Med       Date:  2017-11-14       Impact factor: 30.700

5.  Bronchoalveolar lavage as a possible cause of acute exacerbation in idiopathic pulmonary fibrosis patients.

Authors:  N Hiwatari; S Shimura; T Takishima; K Shirato
Journal:  Tohoku J Exp Med       Date:  1994-12       Impact factor: 1.848

6.  A randomised, placebo-controlled study of omipalisib (PI3K/mTOR) in idiopathic pulmonary fibrosis.

Authors:  Pauline T Lukey; Stephen A Harrison; Shuying Yang; Yim Man; Beverley F Holman; Alaleh Rashidnasab; Gabrielle Azzopardi; Michael Grayer; Juliet K Simpson; Philippe Bareille; Lyn Paul; Hannah V Woodcock; Richard Toshner; Peter Saunders; Philip L Molyneaux; Kris Thielemans; Frederick J Wilson; Paul F Mercer; Rachel C Chambers; Ashley M Groves; William A Fahy; Richard P Marshall; Toby M Maher
Journal:  Eur Respir J       Date:  2019-03-18       Impact factor: 16.671

7.  Host-Microbial Interactions in Idiopathic Pulmonary Fibrosis.

Authors:  Philip L Molyneaux; Saffron A G Willis-Owen; Michael J Cox; Phillip James; Steven Cowman; Michael Loebinger; Andrew Blanchard; Lindsay M Edwards; Carmel Stock; Cécile Daccord; Elisabetta A Renzoni; Athol U Wells; Miriam F Moffatt; William O C Cookson; Toby M Maher
Journal:  Am J Respir Crit Care Med       Date:  2017-06-15       Impact factor: 21.405

8.  The role of bacteria in the pathogenesis and progression of idiopathic pulmonary fibrosis.

Authors:  Phillip L Molyneaux; Michael J Cox; Saffron A G Willis-Owen; Patrick Mallia; Kirsty E Russell; Anne-Marie Russell; Elissa Murphy; Sebastian L Johnston; David A Schwartz; Athol U Wells; William O C Cookson; Toby M Maher; Miriam F Moffatt
Journal:  Am J Respir Crit Care Med       Date:  2014-10-15       Impact factor: 30.528

9.  Diagnosis of Hypersensitivity Pneumonitis in Adults. An Official ATS/JRS/ALAT Clinical Practice Guideline.

Authors:  Ganesh Raghu; Martine Remy-Jardin; Christopher J Ryerson; Jeffrey L Myers; Michael Kreuter; Martina Vasakova; Elena Bargagli; Jonathan H Chung; Bridget F Collins; Elisabeth Bendstrup; Hassan A Chami; Abigail T Chua; Tamera J Corte; Jean-Charles Dalphin; Sonye K Danoff; Javier Diaz-Mendoza; Abhijit Duggal; Ryoko Egashira; Thomas Ewing; Mridu Gulati; Yoshikazu Inoue; Alex R Jenkins; Kerri A Johannson; Takeshi Johkoh; Maximiliano Tamae-Kakazu; Masanori Kitaichi; Shandra L Knight; Dirk Koschel; David J Lederer; Yolanda Mageto; Lisa A Maier; Carlos Matiz; Ferran Morell; Andrew G Nicholson; Setu Patolia; Carlos A Pereira; Elisabetta A Renzoni; Margaret L Salisbury; Moises Selman; Simon L F Walsh; Wim A Wuyts; Kevin C Wilson
Journal:  Am J Respir Crit Care Med       Date:  2020-08-01       Impact factor: 30.528

10.  The Transferrin Receptor CD71 Delineates Functionally Distinct Airway Macrophage Subsets during Idiopathic Pulmonary Fibrosis.

Authors:  Sarah J Allden; Patricia P Ogger; Poonam Ghai; Peter McErlean; Richard Hewitt; Richard Toshner; Simone A Walker; Peter Saunders; Shaun Kingston; Philip L Molyneaux; Toby M Maher; Clare M Lloyd; Adam J Byrne
Journal:  Am J Respir Crit Care Med       Date:  2019-07-15       Impact factor: 21.405
View more
  5 in total

1.  Collagen 1a1 Expression by Airway Macrophages Increases In Fibrotic ILDs and Is Associated With FVC Decline and Increased Mortality.

Authors:  Eliza Tsitoura; Athina Trachalaki; Eirini Vasarmidi; Semeli Mastrodemou; George A Margaritopoulos; Maria Kokosi; Dionysios Fanidis; Apostolos Galaris; Vassilis Aidinis; Elizabeth Renzoni; Nikos Tzanakis; Athol U Wells; Katerina M Antoniou
Journal:  Front Immunol       Date:  2021-11-17       Impact factor: 7.561

2.  Understanding the burden of interstitial lung disease post-COVID-19: the UK Interstitial Lung Disease-Long COVID Study (UKILD-Long COVID).

Authors:  Jim M Wild; Joanna C Porter; Philip L Molyneaux; Peter M George; Iain Stewart; Richard James Allen; Raminder Aul; John Kenneth Baillie; Shaney L Barratt; Paul Beirne; Stephen M Bianchi; John F Blaikley; Jonathan Brooke; Nazia Chaudhuri; Guilhem Collier; Emma K Denneny; Annemarie Docherty; Laura Fabbri; Michael A Gibbons; Fergus V Gleeson; Bibek Gooptu; Ian P Hall; Neil A Hanley; Melissa Heightman; Toby E Hillman; Simon R Johnson; Mark G Jones; Fasihul Khan; Rod Lawson; Puja Mehta; Jane A Mitchell; Manuela Platé; Krisnah Poinasamy; Jennifer K Quint; Pilar Rivera-Ortega; Malcolm Semple; A John Simpson; Djf Smith; Mark Spears; LIsa G Spencer; Stefan C Stanel; David R Thickett; A A Roger Thompson; Simon Lf Walsh; Nicholas D Weatherley; Mark Everard Weeks; Dan G Wootton; Chris E Brightling; Rachel C Chambers; Ling-Pei Ho; Joseph Jacob; Karen Piper Hanley; Louise V Wain; R Gisli Jenkins
Journal:  BMJ Open Respir Res       Date:  2021-09

Review 3.  Bronchoalveolar lavage and lung biopsy in connective tissue diseases, to do or not to do?

Authors:  Sara Tomassetti; Thomas V Colby; Athol U Wells; Venerino Poletti; Ulrich Costabel; Marco Matucci-Cerinic
Journal:  Ther Adv Musculoskelet Dis       Date:  2021-12-08       Impact factor: 5.346

4.  Autoantibodies are present in the bronchoalveolar lavage but not circulation in patients with fibrotic interstitial lung disease.

Authors:  Karim Boustani; Poonam Ghai; Rachele Invernizzi; Richard J Hewitt; Toby M Maher; Quan-Zhen Li; Philip L Molyneaux; James A Harker
Journal:  ERJ Open Res       Date:  2022-02-14

5.  Target inhibition of galectin-3 by inhaled TD139 in patients with idiopathic pulmonary fibrosis.

Authors:  Nikhil Hirani; Alison C MacKinnon; Lisa Nicol; Paul Ford; Hans Schambye; Anders Pedersen; Ulf J Nilsson; Hakon Leffler; Tariq Sethi; Susan Tantawi; Lise Gravelle; Robert J Slack; Ross Mills; Utsa Karmakar; Duncan Humphries; Fredrik Zetterberg; Lucy Keeling; Lyn Paul; Philip L Molyneaux; Feng Li; Wendy Funston; Ian A Forrest; A John Simpson; Michael A Gibbons; Toby M Maher
Journal:  Eur Respir J       Date:  2021-05-27       Impact factor: 16.671
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.